March 2023 For quick navigation, please click on the titles below of the topics featured in this month's issue of Connections. Research QuitlinesTobacco CessationPriority PopulationsE-Cigarettes and Heated Tobacco ProductsTechnologyTobacco UseJob and Conference Announcements
NAQC News
NAQC Town Hall Meeting: Progress of Quitlines since 2004 and Priorities for Moving Forward - Recording is Available. Thank you to everyone who was able to participate in the town hall discussion with NAQC’s Advisory Council, Linda Bailey (former CEO) and Michelle Lynch (new CEO) on progress of the quitline community since 2004 and priorities for moving forward. The slides and the recording from the meeting are locate here.
NAQC Membership FY2024 and Orientation/Refresher Webinar. NAQC’s membership drive for the new fiscal year began earlier this month and we hope all of you will renew your membership for the coming year! To avoid a lapse in your membership benefits, please submit payment for your dues before July 1, 2023 (payments are accepted in a form of a check, credit card payment, and online renewal). Please refer to the membership page for more information.
Please contact NAQC if you would like to participate in an orientation/refresher webinar to learn more about how to get the most from your membership in NAQC!
For questions regarding membership and benefits, please contact Natalia Gromov at 800-398-5489 ext. 701 or membership@naquitline.org. Find more NAQC News in our Newsroom or go back to top.
Time-Sensitive News
Webinar on March 22: SCLC Live Webinar, “Tobacco Regulation in an Evolving Landscape: Update from FDA’s Center for Tobacco Products”. Please join the Smoking Cessation Leadership Center at UCSF for the next live webinar, “Tobacco Regulation in an Evolving Landscape: Update from FDA’s Center for Tobacco Products” on Wednesday, March 22, 2023, at 2:00 pm EDT (60 minutes). Dr. Brian King, PhD, MPH, Director, Center for Tobacco Products, at the FDA will be presenting on this webinar, on this important and timely topic.
Webinar Objectives:
- Describe the current patterns of tobacco product use among adults and youth in the United States.
- Identify FDA’s tobacco regulatory priorities, including application reviews, regulations and guidance, enforcement and compliance, and public health education campaigns.
- Explain future opportunities for tobacco product regulation in the United States, including planned product standards to prohibit menthol in cigarettes, to prohibit flavors in cigars, and to cap the maximum level of nicotine in cigarettes and certain other combusted products to minimally addictive or nonaddictive levels.
- Identify opportunities and resources to promote tobacco product use cessation.
» register today
30th Annual Nicotine Dependence Center Conference: Tobacco Treatment and Digital Care. March 27 - 28, 2023 - ASU Health Futures Center - Phoenix, Arizona The 30th Annual Nicotine Dependence Center Conference reviews current best practice models for providing compassionate, patient-centered care and highlights digital and virtual care options. In addition, the conference presentations provide the latest information on the changing landscape of tobacco and nicotine use and product regulations. » register today
March 31, 2023 - Take Down Tobacco National Day of Action. Take Down Tobacco, a fresh take on Kick Butts Day, is the Campaign for Tobacco-Free Kids’ signature platform for empowering people to stand up and speak out against the tobacco industry. The Take Down Tobacco program is a 365 day a year effort that culminates every spring with the Take Down Tobacco National Day of Action.
The next Take Down Tobacco National Day of Action will be held on March 31, 2023. This year also marks the 27th occurrence of this event, and there have been many important victories since the first Kick Butts Day was held in 1996. » learn more
Deadline of April 11 - Drug-Free Communities Support Program: Application Period is Open. Are you working with communities interested in preventing substance use among youth? The Drug-Free Communities (DFC) Support Program provides community coalitions with funding and technical assistance to mobilize local youth substance use prevention efforts. Since the program’s inception in 1997, the DFC Program has awarded more than 2,700 grants to nearly 1,900 coalitions across all 50 states, U.S. territories, and tribal communities. Applications are currently being accepted through April 11, 2023. Find more Time-Sensitive News in our Newsroom or go back to top.
Cessation and Tobacco Control News Tips from Former Smokers® Campaign 2023 Launched March 6! The 2023 Tips Campaign launched on March 6 and will run until Sunday, September 24. This year’s campaign is similar in timing, duration, and media mix as the 2022 campaign media buy. Spanish language integrations promoting 1-855-DÉJELO-YA began at the same time as the main campaign. Ads in select Asian languages promoting the Asian Smokers Quitline will begin on March 27. » learn more
Looking Back, Looking Ahead: FDA’s Progress on Tobacco Product Regulation in 2022. On Jan. 31, Brian King, director of the Food and Drug Administration’s Center for Tobacco Products (CTP), published a perspective looking back on the Center’s progress on tobacco regulation in 2022, and a look ahead into 2023. The perspective shares information on key priority areas including non-tobacco nicotine, product standards, compliance and enforcement, product review and authorization, public health education, and health equity. » learn more
SAMHSA Releases Improved Treatment Services Locator. SAMHSA welcomes you to the newly improved FindTreatment.gov! The upgraded website is easier to navigate, mobile-friendly, and packed with new features. Built to be the most comprehensive resource for persons seeking treatment for mental and substance use disorders, FindTreatment.gov offers you the ability to: - Search for treatment from multiple sources
- Access an interactive map and search filters
- Search for a facility by entering address, city, zip code, or facility name
- Download printer-friendly search results including facility location
» learn more
New Online Training from ALA and AAP. In a News Release shared on January 4, 2023, the American Lung Association in partnership with the American Academy of Pediatrics, announces the launch a new online training.
According to the 2022 National Youth Tobacco Survey, more than 3 million U.S. middle and high school youth reported currently using any tobacco product. Current use of any tobacco product was higher among certain population groups. Notably, the survey also found that 65% of students who currently use any tobacco product reported seriously thinking about quitting the use of all products. Influential adults who work with youth tobacco users need the resources to intervene and help support them in their quit efforts. To further health equity among the adolescent population, especially for those at highest risk, the American Lung Association offers a new, free online training course for adults who work with youth to provide tools to help them intervene with effective strategies to help support youth tobacco users quit. The American Lung Association announces the launch of the ACT (Ask, Counsel, Treat) to Address Youth Cessation Training. The training is a one-hour course that provides an overview for healthcare professionals, school personnel and community members in youth-supportive roles to conduct a brief intervention for teens who use tobacco. Based on the American Academy of Pediatrics’ Youth Tobacco Cessation: Considerations for Clinicians, the course outlines the steps of Ask, Counsel, Treat, and provides guidance, support and best practices for effectively delivering ACT as a brief intervention for adolescents who identify as tobacco users, including e-cigarettes. Register now to complete this free on-demand training on Lung.Training/courses/act-to-address-youth-cessation How can you help? We encourage you to participate in the training, share the link to those who work with youth and share it throughout your networks of community and corporate partners, coalition members and volunteers. Should you have any questions, please feel free to reach out to NOT@Lung.org. » learn more
New Publication from WHO - "It’s Time to Invest in Cessation: the Global Investment Case for Tobacco Cessation”. The World Health Organization’s publication “It’s time to invest in cessation: the global investment case for tobacco cessation” discusses the far-reaching positive results in terms of lives and dollars saved under the base scenario of implementing six cessation interventions in 124 countries over the next 10 years. Some of these figures include: - Could help 150 million tobacco users quit
- Could save 2.7 million lives, if quitters were followed until 2030; 16 million lives if followed until they reach age 65
- A return on investment of 80 cents on the dollar (measured at the end of 2030) or 7.5 dollars for every 1 dollar if assessed until quitters reach age 65
» learn more Dr. Carolyn Dresler, 2022 C. Everett Koop Unsung Hero Award Recipient, Joins ASH Board of Trustees. "WASHINGTON, DC – JANUARY 24, 2023 – Action on Smoking and Health (ASH US) is honored to welcome Carolyn Dresler, MD, MPA to its Board of Trustees. Dr. Dresler brings decades of clinical lung health and policy expertise to ASH which aligns with our work to end the tobacco epidemic as quickly as possible. Dr. Dresler was trained at Memorial Sloan Kettering and the University of Toronto as a thoracic surgical oncologist with clinical practices at Washington University and Fox Chase Cancer Center. She retired in 2018 as the Associate Director for Medical and Health Sciences for the Office of Science at the Center for Tobacco Products at the U.S. Food and Drug Administration (FDA). Prior to working at the FDA, Dr. Dresler was the Director for the Arkansas Department of Health Tobacco Prevention and Cessation Program. She was also the Head of Unit for Tobacco and Cancer at the International Agency for Research on Cancer in Lyon, France. In 2003, she took a leave of absence to complete a Master in Public Administration at the Kennedy School of Government at Harvard University. During her time at Harvard, Dr. Dresler studied under fellow ASH Board Trustee, Professor Stephen P. Marks, and made a now historic assertion: the tobacco industry violates human rights every day simply by marketing and selling products they know will addict and kill. Dr. Dresler’s Harvard thesis was adapted and published as the landmark piece “The Emerging Human Right to Tobacco Control” in the journal Human Rights Quarterly in 2006. Professor Marks, initially skeptical of the concept, went on to co-author the paper and join her in championing the link between tobacco and human rights. “I was awakened, thanks to Carolyn, to the critical importance of tobacco control not only as a major public health issue but also as a human rights issue,” said Stephen Marks, Dean of the Jindal School of Public Health and Human Development (JSPH) at O.P. Jindal Global University and François-Xavier Bagnoud Professor of Health and Human Rights Emeritus, Harvard University. In 2009, Dr. Dresler became the founder and board chair of the Human Rights and Tobacco Control Network (HRTCN), a global non-governmental organization dedicated to using human rights to end the tobacco epidemic, and invited ASH Policy Director Chris Bostic to join the board. HRTCN membership led to ASH’s human rights program. The network is now housed under ASH as a network of experts supporting the connection of human rights and tobacco control. Dr. Dresler has had a profound impact on the way public health advocates, researchers and officials view the tobacco epidemic. The human rights-based approach provides the foundation for ASH’s cutting-edge policy strategies and focus on health equity in policy outcomes. Recently, Dr. Dresler was awarded the American Lung Association’s 2022 C. Everett Koop Unsung Hero Award “for her remarkable career and contributions she made to significantly reducing tobacco use in Colorado, the U.S. and around the world,” said the American Lung Association in their statement. ASH released a video featuring global colleagues reflecting on Dr. Dresler’s extensive impact to commemorate the occasion. “Dr. Dresler is a force for good in the world. Her efforts to reduce tobacco use and secondhand smoke exposure have undoubtedly impacted millions of lives around the world,” said Harold Wimmer, President and CEO of the American Lung Association. “Her vision has moved the world closer to being free from tobacco.” Dr. Dresler’s goal is to end the tobacco epidemic, not “someday” but soon. Her continued partnership with and support of ASH as a Trustee will no doubt accelerate that goal."
Tobacco Imagery Featured in More Oscar-nominated Movies this Year, Including 90% of Best Picture Nominees. Nine of the 10 films nominated for Best Picture at the 2023 Oscars and more than two-thirds (71.7%) of all this year’s Oscar-nominated feature films contain tobacco imagery, including “Glass Onion: A Knives Out Mystery,” “Top Gun: Maverick,” and “Elvis,” according to a Truth Initiative analysis. This is an increase from the number of 2022 Oscar-nominated films that contained tobacco imagery, underscoring a troubling trend of the renormalization and glamorization of tobacco use in entertainment media and pop culture. » learn more New Documentary Takes Hard Look at Tobacco Industry’s Predatory Tactics for New Generations. Six years after his seminal short film “Black Lives/Black Lungs” documented the decades-long campaign transforming menthol into a Black cigarette, filmmaker and former Truth Initiative fellow Lincoln Mondy released his follow-up documentary exposing the tobacco industry’s efforts to skirt federal regulations. “Black Lives/Black Lungs: The Journey of a Stolen Leaf” unravels the industry’s strategy of protecting profits, subverting regulations, and maintaining influence through the promotion of e-cigarettes to hook a new generation to nicotine. » learn more Find more Cessation and Tobacco Control News in our Newsroom or go back to top.
Research QuitlnesMcQueen A, Wartts JG, Garg R, Carpenter KM, Kreuter MW. Leveling the Playing Field: Mailing Pharmacotherapy to Medicaid Members who Smoke. Am J Prev Med. 2023 Feb;64(2):227-234. doi: 10.1016/j.amepre.2022.09.008. Epub 2022 Nov 3. PMID: 36335079. Introduction. Smoking rates differ by insurance type; rates are often double for Medicaid and uninsured compared with that for Medicare or privately insured. State-funded tobacco quitlines' provision of free nicotine replacement therapy varies. In some states, Medicaid beneficiaries must obtain nicotine replacement therapy from a physician, whereas others get nicotine replacement therapy mailed to them. Methods. This secondary analysis examined the differences in the source and use of cessation treatment by insurance type and their impacts on cessation. The parent trial excluded people who were pregnant, had private insurance, or were not ready to quit. From June 1, 2017 to November 15, 2020, a total of 1,944 low-income people who smoke daily completed a baseline survey and were enrolled in a quitline program; 1,380 (71%) completed a 3-month follow-up. Analyses were completed in August 2022. Participants were classified as Medicaid/dual (55%), Medicare/Veterans Affairs (14%), or uninsured (31%). Nine months into the trial, owing to a system error, the quitline provided nicotine replacement therapy to all study participants regardless of insurance type. Results. Before error versus after error, Medicaid participants reported lower nicotine replacement therapy receipt (3.2% vs 50.8%) and use (32.4% vs 52.6%). The odds of quitting (7-day point prevalence) by 3 months increased for people who smoke who completed more quitline calls and used any (36% quit) versus used no (20% quit) pharmacotherapy, but quitting did not differ by insurance classifications (27%-29%). Getting and using nicotine replacement therapy from the quitline produced the highest quit rates (38%). Conclusions. Results illustrate the benefit of receiving nicotine replacement therapy from the quitline on cessation. Mailing nicotine replacement therapy to all people who smoke should be standard practice to reduce smoking disparities. Grimes LM, Garg R, Weng O, Wolff JM, McQueen A, Carpenter KM, Kreuter MW. Appeal of Tobacco Quitline Services among Low-income Smokers. Prev Chronic Dis. 2023 Mar 2;20:E11. doi: 10.5888/pcd20.220214. PMID: 36862604; PMCID: PMC9983599. Introduction. State tobacco quitlines are delivering cessation assistance through an increasingly diverse range of channels. However, offerings vary from state to state, many smokers are unaware of what is available, and it is not yet clear how much demand exists for different types of assistance. In particular, the demand for online and digital cessation interventions among low-income smokers, who bear a disproportionate burden of tobacco-related disease, is not well understood. Methods. We examined interest in using 13 tobacco quitline services in a racially diverse sample of 1,605 low-income smokers in 9 states who had called a 2-1-1 helpline and participated in an ongoing intervention trial from June 2020 through September 2022. We classified services as standard (used by ≥90% of state quitlines [eg, calls from a quit coach, nicotine replacement therapy, printed cessation booklets]) or nonstandard (mobile app, personalized web, personalized text, online chat with quit coach). Results. Interest in nonstandard services was high. Half or more of the sample reported being very or somewhat interested in a mobile app (65%), a personalized web program (59%), or chatting online with quit coaches (49%) to help them quit. In multivariable regression analyses, younger smokers were more interested than older smokers in digital and online cessation services, as were women and smokers with greater nicotine dependence. Conclusion. On average, participants were very interested in at least 3 different cessation services, suggesting that bundled or combination interventions might be designed to appeal to different groups of low-income smokers. Findings provide some initial hints about potential subgroups and the services they might use in a rapidly changing landscape of behavioral interventions for smoking cessation. Cassidy DG, Wang XQ, Mallawaarachchi I, Wiseman KP, Ebbert JO, Blue Star JA, Aycock CA, Estevez Burns R, Jones JR, Krunnfusz AE, Halbert JP, Roy NM, Ellis JM, Williams JB, Klesges RC, Talcott GW. Tobacco Quitline Performance: Comparing the Impacts of Early Cessation and Proactive Re-engagement on Callers' Smoking Status at Follow-up at 12 Months. Tob Induc Dis. 2023 Feb 15;21:24. doi: 10.18332/tid/159125. PMID: 36798676; PMCID: PMC9923459. Introduction. While tobacco Quitlines are effective in the promotion of smoking cessation, the majority of callers who wish to quit still fail to do so. The aim of this study was to determine if 12-month tobacco Quitline smoking cessation rates could be improved with re-engagement of callers whose first Quitline treatment failed to establish abstinence. Methods. In an adaptive trial, 614 adult smokers, who were active duty, retired, and family of military personnel with TRICARE insurance who called a tobacco Quitline, received a previously evaluated and efficacious four-session tobacco cessation intervention with nicotine replacement therapy (NRT). At the scheduled follow-up at 3 months, callers who had not yet achieved abstinence were offered the opportunity to re-engage. This resulted in three caller groups: 1) those who were abstinent, 2) those who were still smoking but willing to re-engage with an additional Quitline treatment; and 3) individuals who were still smoking but declined re-engagement. A propensity score-adjusted logistic regression model was generated to compare past-7-day point prevalence abstinence at 12 months post Quitline consultation. Results. Using a propensity score adjusted logistic regression model, comparison of the three groups resulted in higher odds of past-7-day point prevalence abstinence at follow-up at 12 months for those who were abstinent at 3 months compared to those who re-engaged (OR=9.6; 95% CI: 5.2-17.8; Bonferroni adjusted p<0.0001), and relative to those who declined re-engagement (OR=13.4; 95% CI: 6.8-26.3; Bonferroni adjusted p<0.0001). There was no statistically significant difference in smoking abstinence between smokers at 3 months who re-engaged and those who declined re-engagement (OR=1.39; 95% CI: 0.68-2.85). Conclusions. Tobacco Quitlines seeking to select a single initiative by which to maximize abstinence at follow-up at 12 months may benefit from diverting additional resources from the re-engagement of callers whose initial quit attempt failed, toward changes which increase callers' probability of success within the first 3 months of treatment. Williams, Brian S., Piper, Megan, Piasecki, Thomas M., Kaye, Jesse, Fiore, Michael.Trends in E-cigarette Use in Callers to the Wisconsin Tobacco Quit Line.WMJ. 2023;122(1):10-14. https://wmjonline.org/122no1/williams/ I ntroduction. E-cigarette use has been increasing for years with a limited understanding of how to help users quit. Quit lines are a potential resource for e-cigarette cessation. Our objective was to characterize e-cigarette users who call state quit lines and to examine trends in e-cigarette use by callers. Methods. This retrospective study examined data from adult callers to the Wisconsin Tobacco Quit Line from July 2016 through November 2020, including demographics, tobacco product use, motivations for use, and intentions to quit. Descriptive analyses were performed by age group with pairwise comparisons. Results. A total of 26,705 encounters were handled by the Wisconsin Tobacco Quit Line during the study period. E-cigarettes were used by 11% of callers. Young adults aged 18-24 had the highest rates of use at 30%, and their use rose significantly from 19.6% in 2016 to 39.6% in 2020. E-cigarette use among young adult callers peaked at 49.7% in 2019, coinciding with an outbreak of e-cigarette-related lung injury. Only 53.5% of young adult callers used e-cigarettes to “cut down on other tobacco,” compared to 76.3% of adult callers aged 45-64 ( P < 0.05). Of all callers using e-cigarettes, 80% were interested in quitting. Conclusions. E-cigarette use among callers to the Wisconsin Tobacco Quit Line has increased, driven largely by young adults. Most e-cigarette users who call the quit line want to quit. Thus, quit lines can serve an important role in e-cigarette cessation. A better understanding of strategies to help e-cigarette users quit is needed, particularly in young adult callers. Tobacco CessationKowitt SD, Mendel Sheldon J, Vereen RN, Kurtzman RT, Gottfredson NC, Hall MG, Brewer NT, Noar SM. The Impact of The Real Cost Vaping and Smoking Ads Across Tobacco Products. Nicotine Tob Res. 2023 Feb 9;25(3):430-437. doi: 10.1093/ntr/ntac206. PMID: 36006858; PMCID: PMC9910139.
Introduction. Little research has examined the spillover effects of tobacco communication campaigns, such as how anti-smoking ads affect vaping. Aims and methods. Participants were a national sample of 623 U.S. adolescents (ages 13-17 years) from a probability-based panel. In a between-subjects experiment, we randomly assigned adolescents to view one of four videos online: (1) a smoking prevention video ad from the Food and Drug Administration's (FDA) The Real Cost campaign, (2) a neutral control video about smoking, (3) a vaping prevention video ad from The Real Cost campaign, or (4) a neutral control video about vaping. We present effect sizes as Cohen's d, standardized mean differences, with 95% confidence intervals (CIs). Results. Exposure to The Real Cost vaping prevention ads led to more negative attitudes toward vaping compared with control (d = 0.30, 95% CI: 0.07, 0.53), while exposure to The Real Cost smoking prevention ads did not affect smoking-related outcomes compared with control (p-values > .05). Turning to spillover effects, exposure to The Real Cost smoking prevention ads led to less susceptibility to vaping (d = -0.34, 95% CI: -0.56, -0.12), more negative attitudes toward vaping (d = 0.43, 95% CI: 0.20, 0.65) and higher perceived likelihood of harm from vaping (d = 0.26, 95% CI: 0.04, 0.48), compared with control. Exposure to The Real Cost vaping prevention ads did not affect smoking-related outcomes compared with control (p-values > .05). Conclusions. This experiment found evidence of beneficial spillover effects of smoking prevention ads on vaping outcomes and found no detrimental effects of vaping prevention ads on smoking outcomes. Implications. Little research has examined the spillover effects of tobacco communication campaigns, such as how anti-smoking ads affect vaping. Using a national sample of 623 U.S. adolescents, we found beneficial evidence of spillover effects of smoking prevention ads on vaping outcomes, which is promising since it suggests that smoking prevention campaigns may have the additional benefit of reducing both smoking and vaping among adolescents. Additionally, we found that vaping prevention campaigns did not elicit unintended consequences on smoking-related outcomes, an important finding given concerns that vaping prevention campaigns could drive youth to increase or switch to using combustible cigarettes instead of vaping.
Chang JT, Mayer M, Jackson RA, Rostron BL, Coleman B, Lee T, Ambrose BK, Chang CM. Characteristics and Patterns of Cigarette Smoking and Vaping by Past-year Smokers who Reported Using Electronic Nicotine Delivery System to Help Quit Smoking in the Past Year: Findings from the 2018-2019 Tobacco Use Supplement to the Current Population Survey. Nicotine Tob Res. 2023 Feb 9;25(3):596-601. doi: 10.1093/ntr/ntac199. PMID: 35973818.
Introduction. Cigarette smoking has declined, while electronic nicotine delivery system (ENDS) use has increased in the United States. Understanding the role of ENDS in adult smoking quit attempts and cessation is important for estimating their population health impact. Aims and methods. We used data from 2018 to 2019 tobacco use supplement to the current population survey to examine demographic characteristics and ENDS use patterns among adult ENDS users who reported quitting smoking in the past year by trying to switch to ENDS ("switchers") and smokers who did or did not make a quit attempt in the past year. χ2 tests of proportions and t-tests were used to compare characteristics between groups. Results. In 2018-2019, about three-quarters of switchers reported daily use of ENDS compared to only one-third of dual users with a recent quit attempt by trying to switch to ENDS. Compared to dual users who made a quit attempt by trying to switch to ENDS, switchers were more likely to use menthol/mint-flavored ENDS exclusively (5.6% vs. 13.1%; p = .004) but less likely to use tobacco-flavored ENDS exclusively (21.2% vs. 13.7%; p = .01). Conclusions. ENDS users who quit smoking in the past year and reported trying to quit by switching to ENDS were more likely to use menthol/mint flavors exclusively and use ENDS daily compared to dual users who made a quit attempt by trying to switch to ENDS. Longer-term prospective data may better clarify the role of ENDS in smoking quit attempts and cessation. Implications. This study provides information on patterns of ENDS use in former smokers and current smokers who tried to quit smoking by switching to ENDS in a national sample of U.S. adults. These results can inform policy actions concerning ENDS products.
Yingst J, Wang X, Lopez AA, Breland A, Soule E, Barnes A, Cohen J, Underwood M, Crabtree M, Foulds J. Changes in Nicotine Dependence among Smokers Using Electronic Cigarettes to Reduce Cigarette Smoking in a Randomized Controlled Trial. Nicotine Tob Res. 2023 Feb 9;25(3):372-378. doi: 10.1093/ntr/ntac153. PMID: 35752091; PMCID: PMC9910150.
Introduction. How nicotine dependence will be affected when current smokers initiate electronic cigarette (e-cigarette) use to reduce cigarette smoking is unknown. This study evaluated cigarette, e-cigarette, and total nicotine dependence more than 6 months among smokers reducing cigarette consumption by replacing with e-cigarettes. Aims and methods. Adult cigarette smokers were randomized to one of four conditions (36 mg/ml e-cigarette, 8 mg/ml e-cigarette, 0 mg/ml e-cigarette, or cigarette-substitute [CS] [provided at no cost]) and instructed to reduce their cigarette smoking by 75% at 1 month. Participants completed follow-up at 1, 3, and 6 months. The Penn State Nicotine Dependence Index (PSNDI) measured dependence on cigarettes (PSCDI) and e-cigarettes (PSECDI). Urine cotinine measured total nicotine exposure. Linear mixed effects models for each outcome were conducted and included interaction terms between visit and condition. Results. Participants (n = 520) were 58.8% female, 67.3% White, and 48.0 years old. At baseline, the median number of cigarettes smoked per day was 17.3 and the mean PSCDI score was 13.4, with no significant differences between conditions. Participants in the e-cigarette conditions reported significantly lower PSCDI scores, compared with baseline, and with the CS condition at all follow-up visits. Those in the 36 mg/ml e-cigarette condition reported greater PSECDI scores at 6 months, compared with baseline and the 0 mg/ml and 8 mg/ml conditions. At all follow-up visits, there were no differences in total nicotine exposure compared to baseline, nor between any conditions. Conclusions. E-cigarette use was associated with reduced cigarette dependence, compared to the CS, without significant increases in total nicotine exposure. Implications. Initiation of electronic cigarette use while continuing to smoke could potentially increase nicotine dependence. In this randomized trial aimed at helping smokers to reduce their cigarette intake, we found that use of an e-cigarette was associated with a reduction in cigarette dependence and an increase in e-cigarette dependence (in the condition with the highest nicotine concentration only), with no long term increase in total nicotine dependence or nicotine exposure.
Tattan-Birch H, Kock L, Brown J, Beard E, Bauld L, West R, Shahab L. E-cigarettes to Augment Stop Smoking In-person Support and Treatment with Varenicline (E-ASSIST): A Pragmatic Randomized Controlled Trial. Nicotine Tob Res. 2023 Feb 9;25(3):395-403. doi: 10.1093/ntr/ntac149. PMID: 35738868; PMCID: PMC9384384.
Aim. To examine whether, in adults receiving behavioral support, offering e-cigarettes together with varenicline helps more people stop smoking cigarettes than varenicline alone. Methods. A two-group, parallel arm, pragmatic randomized controlled trial was conducted in six English stop smoking services from 2019-2020. Adults enrolled onto a 12-week programme of in-person one-to-one behavioral smoking cessation support (N = 92) were randomized to receive either (1) a nicotine e-cigarette starter kit alongside varenicline or (2) varenicline alone. The primary outcome was biochemically verified abstinence from cigarette smoking between weeks 9-to-12 post quit date, with those lost to follow-up considered not abstinent. The trial was stopped early due to COVID-19 restrictions and a varenicline recall (92/1266 participants used). Results. Nine-to-12-week smoking abstinence rates were 47.9% (23/48) in the e-cigarette-varenicline group compared with 31.8% (14/44) in the varenicline-only group, a 51% increase in abstinence among those offered e-cigarettes; however, the confidence interval (CI) was wide, including the possibility of no difference (risk ratio [RR] = 1.51, 95% CI = 0.91-2.64). The e-cigarette-varenicline group had 43% lower hazards of relapse from continuous abstinence than the varenicline-only group (hazards ratio [HR] = 0.57, 95% CI = 0.34-0.96). Attendance for 12 weeks was higher in the e-cigarette-varenicline than varenicline-only group (54.2% vs. 36.4%; RR = 1.49, 95% CI = 0.95-2.47), but similar proportions of participants in both groups used varenicline daily for ≥8 weeks after quitting (22.9% versus 22.7%; RR = 1.01, 95% CI = 0.47-2.20). Estimates were too imprecise to determine how adverse events differed by group. Conclusion. Tentative evidence suggests that offering e-cigarettes alongside varenicline to people receiving behavioral support may be more effective for smoking cessation than varenicline alone. Implications. Offering e-cigarettes to people quitting smoking with varenicline may help them remain abstinent from cigarettes, but the evidence is tentative because our sample size was smaller than planned-caused by Coronavirus Disease 2019 (COVID-19) restrictions and a manufacturing recall. This meant our effect estimates were imprecise, and additional evidence is needed to confirm that providing e-cigarettes and varenicline together helps more people remain abstinent than varenicline alone.
Al-Shawaf M, Grooms KN, Mahoney M, Buchanan Lunsford N, Lawrence Kittner D. Support for Policies to Prohibit the Sale of Menthol Cigarettes and all Tobacco Products among Adults, 2021. Prev Chronic Dis. 2023 Feb 2;20:E05. doi: 10.5888/pcd20.220128. PMID: 36729702.
This study assessed support for commercial tobacco retail policies among adults. Data came from SpringStyles 2021, a web panel survey of adults in the US aged 18 years or older (N = 6,455). Overall, 62.3% of adults supported a policy prohibiting the sale of menthol cigarettes, and 57.3% supported a policy prohibiting the sale of all tobacco products. A majority of adults supported tobacco retail policies aimed at preventing initiation, promoting quitting, and reducing tobacco-related disparities. These findings can help inform federal, state, and local efforts to prohibit the sale of tobacco products, including menthol cigarettes. Priority Populations
McQuoid J, Durazo A, Mooney E, Heffner J, Tan ASL, Kong AY, Clifton S, Horn E. Tobacco Cessation and Prevention Interventions for Sexual and/or Gender Minority-identified People and the Theories that Underpin Them: A Scoping Review. Nicotine Tob Res. 2023 Jan 31:ntad018. doi: 10.1093/ntr/ntad018. Epub ahead of print. PMID: 36721977.
Introduction. This scoping review takes stock of the social and behavior change theories that have underpinned tobacco interventions tailored to sexual and/or gender minority (SGM) people and reflects on the need to target contextually-based drivers of SGM tobacco use inequities. Methods. Data sources were Medline (Ovid), Scopus, PubMed, Google Scholar (01/01/1946 - 10/27/2022). Peer-reviewed publications in English from anywhere in the world describing SGM-tailored tobacco cessation and/or prevention interventions were independently identified by a librarian and screened by the first and third authors. 367 articles were extracted; an additional 2 were found by hand searching. 369 articles were assessed for eligibility. Exclusion criteria were: not an intervention, review article, not SGM-tailored or tobacco-focused. We documented intervention name, intervention components, theoretical frameworks cited in reference to intervention design and/or implementation, and evaluation outcomes. All authors provided input on theoretical framework categorization. Results. We identified 22 publications corresponding to 15 unique interventions. Individual-level behavior change theories (i.e., those focusing on within-person behavior change processes) were the most prominent. Among these, the Transtheoretical Model was the most frequently utilized, while Social Inoculation Theory, Theory of Reasoned Action, and Theory of Psychological Reactance were also employed. A minority of interventions referenced frameworks that more explicitly engaged with SGM people's social contexts, namely, Theory of Diffusion of Innovations and Minority Stress Model. Conclusions. Future SGM-tailored tobacco interventions should leverage both the strengths of individual-level behavior change theories and those of frameworks that understand tobacco use inequities as indivisible from place, context, and policy. Implications. This scoping review describes the theoretical underpinnings of sexual and/or gender minority (SGM)-tailored tobacco interventions published in the peer-review literature in English. It reflects on the need for greater utilization of social and behavior change theoretical frameworks that can engage with unique drivers of SGM tobacco use and barriers to cessation.
E-Cigarettes and Heated Tobacco Products Yong HH, Chow R, East K, Thrasher JF, Hitchman SC, Borland R, Cummings KM, Fong GT. Do Social Norms for Cigarette Smoking and Nicotine Vaping Product Use Predict Trying Nicotine Vaping Products and Attempts to Quit Cigarette Smoking amongst Adult Smokers? Findings from the 2016-2020 International Tobacco Control Four Country Smoking And Vaping Surveys. Nicotine Tob Res. 2023 Feb 9;25(3):505-513. doi: 10.1093/ntr/ntac212. PMID: 36082962; PMCID: PMC9910125.
Introduction. To examine whether perceived injunctive and descriptive social norms towards cigarette and nicotine vaping product (NVP) use predicted subsequent trying NVPs and attempts to quit cigarette smoking amongst current smokers and whether associations varied across countries. Aims and methods. Three waves of longitudinal cohort data from the International Tobacco Control Four Country Smoking and Vaping Survey were collected between 2016 and 2020 from 2290 adult smokers in Canada, Australia, England, and the United States who had never used NVPs at baseline (either wave 1 or wave 2) and followed up at the subsequent wave (wave 2 or wave 3, respectively) were analyzed using Generalized Estimating Equations. Results. Of the injunctive and descriptive norm measures for smoking and NVP use, NVP initiation was only independently predicted by the injunctive interpersonal norm for NVP use, with perceived approval of NVP use by important others predicting higher odds of trying NVPs (AOR = 1.65, 95% CI = 1.20 to 2.27). This predictive effect was independent of baseline quit intention with no country variations found. By contrast, making cigarette smoking quit attempts were independently predicted by both injunctive and descriptive interpersonal norms with perceived disapproval of smoking by important others (AOR = 1.65, 95% CI = 1.38 to 1.99) and close friends using NVPs (AOR = 1.37, 95% CI = 1.04 to 1.79), both associated with higher odds of smoking quit attempts. Conclusions. Adult smokers who perceive NVP use as normative, either because such behavior is socially approved or common within their close social networks, appear more inclined to try NVPs or make smoking quit attempts than smokers who do not. Implications. Social norms can shape a person's behavior and result in behavior change. This study shows that initiation of NVP use behavior among smokers can be reliably predicted by their perception of whether NVP use is acceptable to those important to them within their close social networks. Similarly, any attempts to stop cigarette smoking can be predicted by their perception of how acceptable cigarette smoking is among those who are important to them and whether any of their close friends use NVPs. Changing social norms towards cigarette smoking and NVP use could therefore be incorporated into smoking cessation interventions to help smokers to quit and/or switch to NVP use.
Ozga JE, Stroup AM, Abadi MH, Cheney MK, Majmundar A, Garrison KA, Chen-Sankey J, Shamblen S, Dunlap C, Stanton CA. E-cigarette Marketing Expenditures in the United States from 2016 to 2021: Targeted Media Outlets Geared Toward People who are at Increased Risk for Tobacco Use. Nicotine Tob Res. 2023 Feb 9;25(3):581-585. doi: 10.1093/ntr/ntac209. PMID: 36070398; PMCID: PMC9910151.
Introduction. E-cigarette advertising exposure is linked to e-cigarette initiation and use. Thus, monitoring trends in e-cigarette advertising practices is important to understand e-cigarette use patterns observed over recent years. Aims and methods. E-cigarette advertising expenditures (January 2016-July 2021; Numerator Ad Intel) for 154 U.S. market areas were harmonized with U.S. Census sociodemographic data through Nielsen zip code designations by market area. Descriptive statistics and multivariable linear regressions were used to examine trends in e-cigarette advertising expenditures across media outlets and associations between sociodemographic characteristics and e-cigarette advertising over time. Results. E-cigarette advertising expenditures peaked in 2018/2019, followed by a sharp decline in 2020. Expenditures were concentrated primarily on print (58.9%), TV (20.6%), and radio (14.4%). Major print outlets were Sports Illustrated, Rolling Stone, and Star magazines. Top TV channels were AMC, Investigation Discovery, and TBS. TV advertisements were purchased commonly during popular movies and TV series (eg King of Queens, Everybody Loves Raymond, The Walking Dead). Higher expenditures were associated with U.S. market areas that had (1) a larger percentage of non-rural zip codes (radio), (2) smaller male populations (radio), and (3) larger White or Caucasian, Black or African American, American Indian or Alaska Native, Asian, and Other or Multiracial populations (radio, print, online display, and online video). Conclusions. E-cigarette companies advertised in print magazines geared toward males and youth and young adults, radio commercials focused in urban areas with smaller male populations, and nationwide TV commercials. Declines in e-cigarette advertising expenditures in 2020 demonstrate the potential impact that federal policies may have on protecting populations who are at higher risk for tobacco use from predatory advertising practices. Implications. E-cigarette advertising exposure is associated with the initiation and use of e-cigarettes. This study shows how e-cigarette marketing expenditures in the United States may have targeted specific consumers (eg youth and young adults) between 2016 and 2021. The precipitous drop in advertising expenditures across all outlets during early 2020 corresponds with the implementation of the Tobacco 21 federal policy, the federal enforcement policy to remove most unauthorized flavored e-cigarette cartridges from the U.S. market, preparations for FDA's premarket review of e-cigarette products, and the decision by several TV broadcast companies to stop showing e-cigarette ads. The potential impact of federal policies may have far-reaching implications for protecting populations who are at high risk for tobacco use and its health consequences.
Stone MD, Braymiller JL, Strong DR, Cwalina SN, Dimofte CV, Barrington-Trimis JL. Differentiating Reasons for Young Adult E-cigarette Use Using Maximum Difference Choice Models. Nicotine Tob Res. 2023 Jan 31:ntad017. doi: 10.1093/ntr/ntad017. Epub ahead of print. PMID: 36719042.
Introduction. Understanding the reasons young adults use e-cigarettes (i.e., vape) - and whether these motivations vary across groups - is essential for informing tobacco regulatory efforts. Methods. An online panel of young adults who vape (n=230; age=18-30) completed a maximum difference discrete choice task for 15 reasons for vaping. Over 9 choice sets, participants were presented a subset of 5 reasons and selected the most and least important. Hierarchical bayesian analysis estimated the relative importance of each reason. Latent class analysis (LCA) identified groups with similarly ranked reasons for use. Multinomial regression evaluated the association between sample characteristics and class membership. Results. Overall, relaxation had the highest probability of being the most important reason for use (14.8%), followed by harm reduction (13.2%), and flavors (10.3%). LCA identified five distinct classes, based on top reasons for use: (1) cessation (cigarette cessation [20.2%]; n=80); (2) dependence (relaxation [20.5%] and unable to quit [19.2%]; n=21); (3) relaxation (relaxation [20.6%]; n=66); (4) socializing (socializing [22.2%]; n=27); and (5) variable (boredom [10.5%] and acceptability [10.2%]; n=36). Participants who were older, smoked cigarettes, or vaped more frequently were more likely to belong to the cessation class while those who were younger or more e-cigarette dependent were more likely to belong to the dependence class. Conclusions. Perceived reasons why young adults vape are highly heterogeneous and dependent on the type of user. Tobacco regulatory efforts targeting distinct types of vapers are needed to minimize the adverse public health impact of vaping without compromising appeal for smoking cessation. Implications. E-cigarette use remains high among young adults, with flavors, cost, and harm reduction (vs. combustible cigarettes) among the mostly commonly reported reasons for use. Yet, little is known about how relatively important these reasons are to the individual. Leveraging a maximum difference task, young adults' reasons for use were evaluated on a common interval scale and groups sharing similar reasons identified. Smoking cessation, dependence, relaxation, socialization, and boredom were respectively the most important reasons for use among five classes of vapers. E-cigarette regulatory policies should consider the distinct reasons for use as to not compromise their appeal for smoking cessation.
Milstred AR, Douglas AE, Romm KF, Blank MD. Evaluation of the Psychometric Properties of Dependence Measures for Exclusive Electronic Cigarette Users. Nicotine Tob Res. 2023 Feb 9;25(3):563-570. doi: 10.1093/ntr/ntac260. PMID: 36377569; PMCID: PMC9910153.
Introduction. Extant electronic cigarette (ECIG) dependence measures are largely adapted from those designed for cigarette smoking, though few have been evaluated for their psychometric properties. Aims and methods. Never-smoking ECIG users (N = 134) participating in an online survey completed four dependence measures: Penn state electronic cigarette dependence index (PSECDI), e-cigarette dependence scale (EDS-4), diagnostic and statistical manual for tobacco use disorder (DSM-5), and Glover Nilsson behavioral questionnaire (GNBQ). They also reported on their ECIG use characteristics (eg, behaviors and reasons). Results. Internal consistency was highest for the EDS-4 (Cronbach's α = 0.88) followed by the GNBQ (α = 0.75), PSECDI (α = 0.72), and DSM (α = 0.71). Confirmatory factor analyses revealed a single-factor structure for the PSECDI, EDS-4, and GNBQ. For the DSM-5, however, two items did not load significantly (ECIG use interferes with responsibilities; reduce/give up activities because of ECIG use). Significant correlations were observed between all measures and the number of ECIG use days/week and/or years using ECIGs, as well as between DSM-5 scores and the number of ECIG quit attempts and initiation age. Endorsement of using ECIGs because "I like flavors" was correlated positively with DSM-5 and GNBQ scores. Conclusions. All dependence measures evaluated herein demonstrated adequate reliability and construct validity. Future work should focus on determining which aspects of dependence are those that are unique to ECIG use, and subsequently developing a more comprehensive measure of ECIG dependence. Implications. The measures assessed herein-PSECDI, EDS-4, DSM-5, and GNBQ-demonstrated adequate to good reliability and construct validity among a sample of never-smoking ECIG users. The dependence domains covered across measures were related yet distinct. Findings demonstrate the need for future evaluation of these different domains to determine which are the most salient characteristics of ECIG dependence.
Mok Y, Jeon J, Levy DT, Meza R. Associations Between E-cigarette Use and E-cigarette Flavors with Cigarette Smoking Quit Attempts and Quit Success: Evidence from a U.S. Large, Nationally Representative 2018-2019 Survey. Nicotine Tob Res. 2023 Feb 9;25(3):541-552. doi: 10.1093/ntr/ntac241. PMID: 36250607; PMCID: PMC9910159.
Introduction. Although many studies have examined the association between e-cigarette use and smoking cessation, fewer have considered the impact of e-cigarette flavors on cessation outcomes. This study extends previous studies by examining the effects of e-cigarette use and e-cigarette flavors on quit attempts and quit success of smoking. Aims and methods. We used data from the 2018-2019 Tobacco Use Supplement-Current Population Survey (TUS-CPS) survey. Multivariate logistic regression analyses were used to investigate the associations between flavored e-cigarette use with quit attempts and quit success of smoking among individuals who smoked 12 months ago. Two current e-cigarette use definitions were used in these logistic regression analyses; currently use every day or some days versus 20+ days in the past 30 days. Results. Compared to those not using e-cigarettes, current every day or someday e-cigarette use with all nontobacco flavors had an adjusted odds ratio (AOR) of 2.9 (95% CI: 2.4 to 3.5) for quit attempts and 1.7 (95% CI: 1.3 to 2.2) for quit success. 20+ days e-cigarette use with flavors had stronger associations with quit attempts (AOR = 4.2, 95% CI: 3.1 to 5.5) and quit success (AOR = 4.0, 95% CI: 2.9 to 5.4). E-cigarette users with nontobacco flavors were more likely to succeed in quitting compared to those exclusively using non-flavored or tobacco-flavored e-cigarettes. Menthol or mint flavor users had slightly higher odds of quit attempts and success than users of other nontobacco flavors. Conclusions. E-cigarette use is positively associated with both making smoking quit attempts and quit success. Those using flavored e-cigarettes, particularly menthol or mint, are more likely to quit successfully. Implications. E-cigarette use is positively associated with both making a quit attempt and quit success, and those using flavored e-cigarettes are more likely to successfully quit smoking, with no statistically significant differences between the use of menthol or mint-flavored e-cigarettes versus the use of other nontobacco flavored products. This suggests that the potential for e-cigarettes to help people who currently smoke quit could be maintained with the availability of menthol or mint-flavored e-cigarettes, even if other nontobacco flavored products, which are associated with e-cigarette use among youth, were removed from the market.
Felicione NJ, Kaiser L, Leigh NJ, Page MK, Block AC, Schurr BE, O'Connor RJ, Goniewicz ML. Comparing POD and MOD Ends Users' Product Characteristics, Use Behaviors, and Nicotine Exposure. Nicotine Tob Res. 2023 Feb 9;25(3):498-504. doi: 10.1093/ntr/ntac211. PMID: 36073762; PMCID: PMC9910144.
Introduction. POD electronic nicotine delivery systems (ENDS), often containing high concentrations of nicotine salts, have replaced MODs (ie, open/modifiable devices) as the most popular devices. The purpose of this study was to compare device/liquid characteristics, use behavior, and nicotine exposure between POD and MOD users. Methods. Data from the initial visit of a prospective observational study of exclusive ENDS users compared MOD (n = 48) and POD (n = 37) users. Participants completed questionnaires on demographic characteristics, patterns of ENDS use, and ENDS features. A urine sample was collected to test for cotinine and an ENDS liquid sample was collected to test for nicotine and salts. Puff topography was captured during an ad libitum bout at the end of the session. Results. MOD and POD users did not differ on demographic characteristics. MOD users reported purchasing more liquid in the past month than POD users (180.4 ± 28.0 vs. 50.9 ± 9.0 ml, p < .001). Differences in characteristics of devices used by MOD and POD users included flavor type (p = .029), nicotine concentration (liquids used by MOD users contained less nicotine than those used by POD users: 8.9 ± 2.0 vs. 41.6 ± 3.2 mg/ml, p < .001), and presence of the nicotine salt (fewer MOD liquids had salts present than POD liquids: 11.9% vs. 77.4%, p < .001). User groups did not differ on urinary cotinine levels or puff topography (ps > .05). Conclusions. Despite different characteristics of MOD and POD ENDS, users of those products are exposed to similar amounts of nicotine, likely due to using more liquid among MOD users. Implications. This study directly compares ENDS product characteristics, user behavior, and nicotine exposure between MOD and POD ENDS users. Although POD products contained higher nicotine concentrations compared to MOD products, users of PODs reported consuming less liquid than MOD users. Ultimately, MOD and POD users were exposed to similar levels of nicotine, suggesting users behaviorally compensate for differences in product characteristics.
Shafie-Khorassani F, Piper ME, Jorenby DE, Baker TB, Benowitz NL, Hayes-Birchler T, Meza R, Brouwer AF. Associations of Demographics, Dependence, and Biomarkers with Transitions in Tobacco Product Use in a Cohort of Cigarette Users and Dual Users of Cigarettes and E-cigarettes. Nicotine Tob Res. 2023 Feb 9;25(3):462-469. doi: 10.1093/ntr/ntac207. PMID: 36037523; PMCID: PMC9910158.
Introduction. It is uncertain whether e-cigarettes facilitate smoking cessation in the real world. We aimed to understand whether and how transitions among cigarette, e-cigarette, and dual use are associated with sociodemographics, dependence measures, and biomarkers. Aims and methods. We followed 380 adult daily cigarette users and dual users every 2 months for up to 2 years. We estimated transition rates between noncurrent, cigarette-only, e-cigarette-only, and dual use states using a multistate transition model. We estimated univariable hazard ratios (HR) for demographics, dependence measures for cigarettes and e-cigarettes, biomarkers, spousal or partner behaviors, and other measures. Results. We estimated that participants transitioned from cigarette-only to e-cigarette-only through a period of dual use. Dual users ceased smoking (transitioning to e-cigarette-only use) at a greater rate than cigarette-only users did (HR 2.44, 95% CI: 1.49, 4.02). However, of the 60% of dual users estimated to transition to single product use in 1 year, 83% would transition to cigarette-only use and only 17% to e-cigarette-only use. E-cigarette dependence measures were generally associated with reduced e-cigarette cessation rather than enhanced cigarette cessation. E-cigarette users motivated by harm or toxicity reduction or because of restrictions on where or when they could smoke had reduced rates of smoking relapse. Cigarette dependence and spousal smoking were barriers to cigarette cessation for dual users, while using e-cigarettes first in the morning, motivation to quit smoking, and sensory, social, and emotional enjoyment of e-cigarettes (secondary dependence motives) were facilitators of smoking cessation among dual users. Conclusions. Tobacco control policy and interventions may be informed by the barriers and facilitators of product transitions. Implications. Although e-cigarettes have the potential to promote smoking cessation, their real-world impact is uncertain. In this cohort, dual users were more likely to quit smoking than cigarette-only users, but the overall impact was small because most dual users returned to cigarette-only use. Moreover, e-cigarette dependence promoted continued dual use rather than smoking cessation. Yet, high motivation to quit smoking and the sensory, social, and emotional enjoyment of e-cigarettes facilitated smoking cessation in dual users. Better understanding the barriers and facilitators of transitions can help to develop regulations and interventions that lead to more effective use of e-cigarettes for smoking cessation.
Azagba S, Ebling T, Shan L. Sexual Minority Youth E-cigarette Use. Pediatrics. 2023 Mar 1;151(3):e2022058414. doi: 10.1542/peds.2022-058414. PMID: 36808534.
Background and objectives. There is consistent evidence that sexual minority youth (SMY) use more traditional cigarettes than their non-SMY counterparts. However, there is relatively less information on e-cigarettes and, importantly, differences between and within SMY populations by race and ethnicity and sex. This study examines e-cigarette use by sexual orientation status and the intersection of race and ethnicity and sex. Methods. Data come from high school students in the 2020 and 2021 National Youth Tobacco Surveys (N = 16 633). Current e-cigarette use prevalence by sexual identity categories was calculated for racial and ethnic subgroups. Multivariable logistic regression analysis examined the association between sexual identity and e-cigarette use by race and ethnicity groups and sex. Results. E-cigarette use prevalence was higher for most SMY racial and ethnic groups than their non-SMY counterparts. However, multivariable logistic analysis showed varied results by race and ethnic groups, with higher e-cigarette use odds for SMY populations, although not statistically significant for some race and ethnic groups. Black gay or lesbian (adjusted odds ratio: 3.86, 95% confidence interval, 1.61-9.24) and bisexual (adjusted odds ratio: 3.31, 95% confidence interval, 1.32-8.30) high school students had significantly higher e-cigarette use odds than Black heterosexuals. Non-Hispanic Black females e-cigarettes use odds are 0.45 times that of non-Hispanic white males, and non-Hispanic other gay or lesbian had 3.15 times higher e-cigarette use odds than non-Hispanic white heterosexuals. Conclusions. E-cigarette use is more prevalent among SMY populations. Disparities in e-cigarette use vary depending on race and ethnicity and sex.
Technology
Bricker J, Miao Z, Mull K, Santiago-Torres M, Vock DM. Can a Single Variable Predict Early Dropout from Digital Health Interventions? Comparison of Predictive Models from Two Large Randomized Trials. J Med Internet Res. 2023 Jan 20;25:e43629. doi: 10.2196/43629. PMID: 36662550; PMCID: PMC9898835.
Background. A single generalizable metric that accurately predicts early dropout from digital health interventions has the potential to readily inform intervention targets and treatment augmentations that could boost retention and intervention outcomes. We recently identified a type of early dropout from digital health interventions for smoking cessation, specifically, users who logged in during the first week of the intervention and had little to no activity thereafter. These users also had a substantially lower smoking cessation rate with our iCanQuit smoking cessation app compared with users who used the app for longer periods. Objective. This study aimed to explore whether log-in count data, using standard statistical methods, can precisely predict whether an individual will become an iCanQuit early dropout while validating the approach using other statistical methods and randomized trial data from 3 other digital interventions for smoking cessation (combined randomized N=4529). Methods. Standard logistic regression models were used to predict early dropouts for individuals receiving the iCanQuit smoking cessation intervention app, the National Cancer Institute QuitGuide smoking cessation intervention app, the WebQuit.org smoking cessation intervention website, and the Smokefree.gov smoking cessation intervention website. The main predictors were the number of times a participant logged in per day during the first 7 days following randomization. The area under the curve (AUC) assessed the performance of the logistic regression models, which were compared with decision trees, support vector machine, and neural network models. We also examined whether 13 baseline variables that included a variety of demographics (eg, race and ethnicity, gender, and age) and smoking characteristics (eg, use of e-cigarettes and confidence in being smoke free) might improve this prediction. Results. The AUC for each logistic regression model using only the first 7 days of log-in count variables was 0.94 (95% CI 0.90-0.97) for iCanQuit, 0.88 (95% CI 0.83-0.93) for QuitGuide, 0.85 (95% CI 0.80-0.88) for WebQuit.org, and 0.60 (95% CI 0.54-0.66) for Smokefree.gov. Replacing logistic regression models with more complex decision trees, support vector machines, or neural network models did not significantly increase the AUC, nor did including additional baseline variables as predictors. The sensitivity and specificity were generally good, and they were excellent for iCanQuit (ie, 0.91 and 0.85, respectively, at the 0.5 classification threshold). Conclusions. Logistic regression models using only the first 7 days of log-in count data were generally good at predicting early dropouts. These models performed well when using simple, automated, and readily available log-in count data, whereas including self-reported baseline variables did not improve the prediction. The results will inform the early identification of people at risk of early dropout from digital health interventions with the goal of intervening further by providing them with augmented treatments to increase their retention and, ultimately, their intervention outcomes.
Elling JM, Crutzen R, Talhout R, de Vries H. Effects of Providing Tailored Information About E-cigarettes in a Digital Smoking Cessation Intervention: Randomized Controlled Trial. Health Educ Res. 2023 Feb 2:cyad004. doi: 10.1093/her/cyad004. Epub ahead of print. PMID: 36727168.
The effectiveness of e-cigarettes in smoking cessation is under debate. Informing smokers who are motivated to quit smoking about e-cigarettes may help them to make an informed decision about their use for smoking cessation, which, however, may also lead to unintended effects such as less quitting. This experimental study assessed the influence of providing tailored information about e-cigarettes in a web-based tailored smoking cessation intervention on participants' decision-making and smoking behavior. Adult smokers (N = 331) were randomized into a personalized eHealth intervention on (i) smoking cessation (control condition) or (ii) smoking cessation and information about e-cigarettes (intervention condition). Directly postintervention, participants in the intervention condition had more knowledge about e-cigarettes than participants in the control condition. Attitudes toward e-cigarettes were more positive among intervention participants than control participants, but the differences in attitude were less pronounced than the differences in knowledge and not consistent across items. At a 6-month follow-up, no between-condition differences were observed in the use of e-cigarettes as a smoking cessation method, the number of tobacco cigarettes smoked in the past 7 days, or other smoking outcomes.
Tobacco Use
Dai HD, Leventhal AM. Use of Traditional Smokeless, Snus, and Dissolvable Tobacco among U.S. Youth. Am J Prev Med. 2023 Feb;64(2):204-212. doi: 10.1016/j.amepre.2022.09.011. Epub 2022 Nov 3. PMID: 36335080.
Introduction. Snus, dissolvable, and traditional smokeless tobacco product use is often amalgamated in youth epidemiologic research despite differences across these products. Prevalence, trends, and correlates of U.S. youth use across different classes of oral tobacco products are unknown. Methods. Using 2011-2020 National Youth Tobacco Survey (N=193,933) data, the authors tested for cross-year linear and quadratic trends in the weighted prevalence of ever and current use of traditional smokeless tobacco, snus, and dissolvable tobacco. Multivariable logistic regressions estimated the demographic and tobacco use factors associated with the use of different oral tobacco products in 2020. Analyses were conducted in 2022. Results. During 2011-2020, there were declines in the prevalence of ever use of traditional smokeless tobacco (11.0% to 5.6%; linear trend, p<0.0001) and snus (5.2% to 2.4%; p<0.0001) but no change in ever dissolvable tobacco use (0.8%-1.2%). In 2020, an estimated 1,546,000 U.S. youth ever used traditional smokeless tobacco (7.7% high school, 3.0% middle school), 662,000 ever used snus (high school: 3.5%, middle school: 1.0%), and 326,000 ever used dissolvables (high school: 1.5%, middle school: 0.8%). In 2020, females and non-Hispanic Blacks and Hispanics had lower smokeless or snus ever use odds than males and non-Hispanic Whites, respectively, whereas sexual minorities (than heterosexuals) or those speaking a language other than English at home were more likely to report ever use of dissolvable tobacco. Flavored tobacco use was common, particularly for dissolvable current users (72.8% used any flavor). Conclusions. Differences in the epidemiology of oral tobacco use across product types among U.S. youth suggest that oral tobacco products should be disaggregated in future research and policy strategies.
Parms TA, Valverde R, Park-Lee E, Graham-Glover BS, Cunningham CS, Sawdey MD, Cullen KA. Symptoms of Tobacco Dependence among Middle and High School Tobacco Users - Data from the 2019-2020 National Youth Tobacco Survey. Addict Behav. 2023 Feb;137:107537. doi: 10.1016/j.addbeh.2022.107537. Epub 2022 Oct 29. PMID: 36332518; PMCID: PMC9712249.
Introduction. Previous studies have indicated that youth who use tobacco products, including cigarettes, cigars, and smokeless tobacco, demonstrate dependence symptoms. However, the tobacco marketplace has expanded dramatically in recent years, and few studies have examined dependence symptoms among youth who use novel products. This study combined 2019-2020 National Youth Tobacco Survey data to report the prevalence and determinants of tobacco dependence symptoms among U.S. middle and high school current (past 30-day) tobacco users. Methods. Prevalence estimates were calculated to examine dependence outcomes and other covariates by user groups (single product users and multiple product users). Multivariable logistic regression analyses were used to identify independent predictors of tobacco dependence among current users of cigarettes, cigars (regular cigars, cigarillos, and little cigars), e-cigarettes, heated tobacco products, hookah, pipe tobacco, bidis, and smokeless tobacco products (chew, snuff, dip, snus, and dissolvables). Results. Among current tobacco users, 15.7 % (95 % CI: 14.2-17.3) reported wanting to use tobacco within 30 min of waking and 28.3 % (95 % CI: 26.3-30.5) reported strong cravings for tobacco in the past 30 days. Nearly-two-thirds of current users were single product users, of which 80.5 % reported using e-cigarettes. Reporting of dependence symptoms was generally associated with multiple product use, higher frequency of use, earlier initiation age, and use of flavored products. Conclusions. Among U.S. adolescents, a considerable amount of current tobacco product users, even infrequent users, reported symptoms of dependence. These findings highlight the continued importance of prevention strategies for youth tobacco experimentation and progression to regular use.
Tynan MA, Cohen MA, Harris JR. What Happens in Vegas, Stays in your Lungs: An Assessment of Fine Particulate Matter in Casinos that Prohibit and Allow Smoking in Las Vegas, Nevada, USA. Tobacco Control Published Online First: 23 February 2023. doi: 10.1136/tc-2022-057861 Introduction. Despite progress in adoption of smoke-free policies, smoking in casinos is allowed in some US states, including Nevada. In 2020, for the first time, a resort-style casino in Las Vegas prohibited smoking voluntarily. This study is the first to assess air quality in this casino and compare results with similar casinos that allow smoking. Methods. A real-time personal aerosol monitor evaluated particulate matter with a diameter <2.5 µm (PM2.5), a surrogate for secondhand smoke (SHS). PM2.5 was measured at eight Las Vegas casinos, including the smoke-free casino. Each casino was visited twice, and PM2.5 was assessed in smoking-permitted gaming areas and areas where smoking is otherwise prohibited. Results. Average PM2.5 levels were significantly higher in casinos that allow smoking, for both casino gaming areas and areas where smoking is otherwise prohibited (p<0.05). Mean PM2.5 in gaming areas was 164.9 µg/m3 in casinos that allow smoking and 30.5 µg/m3 in the smoke-free casino. Mean PM2.5 in areas where smoking is otherwise prohibited was 83.2 µg/m3 in casinos which allowed smoking in gaming areas, and 48.1 µg/m3 in the smoke-free casino. Conclusion. Despite robust evidence about the harms of SHS, tens of thousands of casino employees and tens of millions of tourists are exposed to high levels of SHS in Las Vegas casinos annually, with PM2.5 levels 5.4 times higher in gaming areas when compared with a smoke-free casino. The only way to protect people from SHS exposure is to prohibit smoking in all indoor areas.
Job and Conference AnnouncementsIf you have any job openings that would interest tobacco control professionals, please send them to us at naqc@naquitline.org.Scientific Position in NCI's Tobacco Control Research Branch: Letters of Interest Welcome.The NCI Tobacco Control Research Branch now welcomes letters of interest from researchers with training and experience in tobacco control and prevention to join the Tobacco Control Research Branch (TCRB). A link to the full announcement is located here: https://cancercontrol.cancer.gov/brp/career-training-opportunities and https://cancercontrol.cancer.gov/sites/default/files/2023-02/LOI_Announcement.pdfKick It California, CA Statewide Quitline, Open Position - Assistant Behavioral Health Clinical Director.Kick It California's is currently looking for an Assistant Behavioral Health Clinical Director. The Assistant Clinical Director is a mental health clinician who will help the Clinical Director manage the clinical operations of Kick It California. The Assistant Clinical Director will apply behavioral change theory with an in-depth understanding of the modification of addictive behaviors in the Quitline setting. KIC serves a range of tobacco users and non-tobacco users from varying ethnic, socioeconomic and psychiatric health backgrounds and includes populations such as teens, American Indians, LGBTQ tobacco users, tobacco users with mental health conditions, First 5 clients (pregnant tobacco users and smokers living with children 0-5), nonsmoking family members and friends of smokers (proxies) and those using e-cigarettes and vaping nicotine. Learn more here. Position Announcement at Arizona Smokers' HelpLine (ASHLine): Tobacco Cessation Consultant.We would like to inform you of a position opening - ASHLine Cessation Manager The Arizona Department of Health Services is seeking a full-time contractor to serve as the Arizona Smokers’ Helpline (ASHLine) Cessation Manager. Please see the position description here. The Cessation Manager is responsible for the strategic direction and oversight of the ASHLine and the coordination of related projects and initiatives, including initiatives to improve the quality, accessibility, cultural responsiveness and impact of quitline services on populations experiencing disparities. This position serves as the Office of Tobacco Prevention and Cessation’s subject matter expert in tobacco cessation. This position is responsible for the quitline program and contract management. This position is also responsible for developing and maintaining internal and external partnerships to support and advance the ASHLine. The Cessation Manager reports to the Office Chief of the Tobacco Prevention and Cessation Program. For more information, please contact Emily Carlson, Office Chief, at Emily.Carlson@azdhs.gov. May 9-11, 2023: The NNPHI Annual Conference is Headed to DC!The National Network of Public Health Institutes (NNPHI) is proud to announce its 22nd Annual Conference will be held May 9-11, 2023 in Washington, DC. Early Bird registration is happening and YOU SHOULD BE THERE to engage in the dynamic NNPHI programming that explores innovative concepts and strategies for advancing health equity and supporting the public health workforce. NNPHI is thrilled to announce Dr. Sacoby Wilson as a keynote speaker at the 2023 NNPHI Annual Conference! Dr. Sacoby Wilson is a Professor with the Maryland Institute for Applied Environmental Health and Department of Epidemiology and Biostatistics, School of Public Health, University of Maryland-College Park. Dr. Wilson has over 20 years of experience as an environmental health scientist and we are honored to have Dr. Wilson join us at the conference to keep this conversation in the forefront and share his thoughts on how we can make environmental justice a public health priority. Register today to gain first access to attendee information, special session announcements, and more. Learn more here. Find more Job and Conference Announcements in our Newsroom or go back to top.
Funding for Connections is provided solely through a cooperative agreement from the Centers for Disease Control and Prevention (5 NU58DP006704-04-00). We thank them for their support of this publication. Information and links are provided solely as a service to NAQC members and partners and do not constitute an endorsement of any organization by NAQC, nor should any be inferred. |